AbCellera Biologics (ABCL) EPS (Basic) (2020 - 2026)
AbCellera Biologics (ABCL) posted EPS (Basic) of -$0.14 for Q1 2026, down 375.61% on a QoQ basis from -$0.03 in Q4 2025, and up 7.06% year-over-year from -$0.13 in Q1 2025.
AbCellera Biologics (ABCL) EPS (Basic) (2020 - 2026) Analysis & Trends
AbCellera Biologics' EPS (Basic) history runs 7 years deep, the most recent figure standing at -$0.14 for Q1 2026.
- Quarterly EPS (Basic) rose 7.06% year-over-year to -$0.14 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.47 (up 15.77% YoY) and the FY2025 annual result came in at -$0.49, up 11.42% from the prior year.
- EPS (Basic) was -$0.14 for Q1 2026 at AbCellera Biologics, down from -$0.03 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.59 in Q1 2022 and bottomed at -$0.19 in Q3 2025.
- A 5-year average of -$0.07 and a median of -$0.12 in 2025 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2022 — EPS (Basic) jumped 221.74% — and 2023, when it plunged 343.36%.
- AbCellera Biologics' EPS (Basic) stood at -$0.1 in 2022, then sank by 55.49% to -$0.16 in 2023, then increased by 28.72% to -$0.12 in 2024, then surged by 74.24% to -$0.03 in 2025, then plunged by 375.61% to -$0.14 in 2026.
- Business Quant data shows ABCL's EPS (Basic) at -$0.14 in Q1 2026, -$0.03 in Q4 2025, and -$0.19 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | AbCellera Biologics | 1.62 Bn | 1.62 Bn | - | -0.14 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.14 |
| Dec 31, 2025 | -0.03 |
| Sep 30, 2025 | -0.19 |
| Jun 30, 2025 | -0.12 |
| Mar 31, 2025 | -0.15 |
| Dec 31, 2024 | -0.12 |
| Sep 30, 2024 | -0.17 |
| Jun 30, 2024 | -0.13 |
| Mar 31, 2024 | -0.14 |
| Dec 31, 2023 | -0.16 |
| Sep 30, 2023 | -0.10 |
| Jun 30, 2023 | -0.11 |
| Mar 31, 2023 | -0.14 |
| Dec 31, 2022 | -0.10 |
| Sep 30, 2022 | 0.09 |
| Jun 30, 2022 | -0.02 |
| Mar 31, 2022 | 0.59 |
| Dec 31, 2021 | 0.22 |
| Sep 30, 2021 | -0.08 |
| Jun 30, 2021 | -0.01 |